Advanced Medical Solutions Group (LON:AMS) Shares Pass Below 200 Day Moving Average – Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 216.99 and traded as low as GBX 214. Advanced Medical Solutions Group shares last traded at GBX 214, with a volume of 1,200,539 shares traded.

Analyst Ratings Changes

AMS has been the subject of several recent research reports. Berenberg Bank reissued a “buy” rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a report on Tuesday, May 19th. Royal Bank Of Canada reissued a “sector perform” rating and set a GBX 260 price objective on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Advanced Medical Solutions Group presently has an average rating of “Moderate Buy” and a consensus target price of GBX 270.25.

Advanced Medical Solutions Group Trading Down 2.9%

The company has a current ratio of 2.79, a quick ratio of 4.58 and a debt-to-equity ratio of 31.50. The company has a market capitalization of £464.87 million, a P/E ratio of 47.35, a PEG ratio of 5.00 and a beta of 0.71. The business has a 50 day moving average price of GBX 227.28 and a 200 day moving average price of GBX 216.99.

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings results on Wednesday, March 18th. The company reported GBX 11.98 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. Analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.